Benefits :
1.Cancer Management: Multiple Myeloma (cancer of plasma cells) and Mantle Cell Lymphoma (a type of non-Hodgkin’s lymphoma).
2.Reduced Bone Destruction: In multiple myeloma patients, this medication helps prevent the destruction of bones.
3.Combination Therapy Efficacy: Bortenat enhances the effectiveness of other chemotherapy agents, such as dexamethasone, thalidomide, or rituximab, providing a stronger combined effect against the disease.
BORTENAT 3.5mg/ml Injection (Bortezomib) Supplier, Dealer, Exporter
We City drug house exporters Is The Leading Supplier, Dealer, Exporter For BORTENAT 3.5mg/ml Injection (Bortezomib) In washington, USA and Nagpur INDIA.
